课题基金 / 基金详情

项目摘要

项目成果

Ali I. Fattom的其他基金

相似基金

相关文献

中文摘要
翻译
NIAID/DAIT佐剂开发项目支持通过免疫学特性研究和先导化合物优化开发新的候选疫苗佐剂,直至并包括ind研究,所有这些都是为了获得人类使用的许可。佐剂将与目前许可的或新的研究性疫苗一起研究,以防止NIAID新发和再发传染病病原体的感染。
英文摘要
The NIAID/DAIT Adjuvant Development Program supports the development of new candidate vaccine adjuvants through immunological characterization studies and lead compound optimization, up to and including IND-enabling studies, all towards licensure for human use. Adjuvants will be studied with currently licensed or new investigational vaccines to protect against infection by NIAID emerging and re-emerging infectious disease pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10884987
  • 项目类别:
  • 资助金额:
    $7.93万
  • 财政年份:
    2020
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10018153
  • 项目类别:
  • 资助金额:
    $29.99万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY.
  • 批准号:
    10250294
  • 项目类别:
  • 资助金额:
    $291.65万
  • 财政年份:
    2019
  • 负责人:
    Ali I. Fattom
  • 依托单位:
Pre-Clinical Development of a Intranasal Bivalent gD2/gB2 HSV-2 Mucosal Vaccine
  • 批准号:
    10076038
  • 项目类别:
  • 资助金额:
    $99.87万
  • 财政年份:
    2017
  • 负责人:
    Ali I. Fattom
  • 依托单位:
海外基金